Preincubation of TRPM2 inhibitor N-(p-amylcinnamoyl) anthranilic acid (20 μM) or knockdown of TRPM2 alleviates obesity-associated impairment in insulin-evoked endothelium-dependent relaxations in obese mice. The gene discussed is TRPM2; the disease is obesity due to melanocortin 4 receptor deficiency.